Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Exercise/Conversion of 3,334 URGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 3,334 | n/a |
| Feb 11, 2026 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 5,500 | n/a |
| Sep 9, 2025 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 3,333 | n/a |
| Jul 30, 2025 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 16,500 | n/a |
| Feb 4, 2025 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 2,500 | n/a |
| Sep 12, 2024 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 3,333 | n/a |
| Feb 3, 2024 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 834 | n/a |
| Sep 8, 2023 | UroGen Pharma Ltd. (URGN) | Grant/Award | 10,000 | n/a |
| Sep 5, 2023 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 8,334 | n/a |
| Feb 2, 2023 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 833 | n/a |